Anti-angiogenesis approach to genitourinary cancer treatment.
about
A novel tissue model for angiogenesis: evaluation of inhibitors or promoters in tissue level.The induction of apoptosis in SGC-7901 cells through the ROS-mediated mitochondrial dysfunction pathway by a Ir(III) complex.Synthesis, docking and biological activities of novel hybrids celecoxib and anthraquinone analogs as potent cytotoxic agents.A novel angiogenesis inhibitor impairs lovo cell survival via targeting against human VEGFR and its signaling pathway of phosphorylationTargeting the VEGF pathway in metastatic bladder cancer.Antiangiogenic properties of substituted (Z)-(±)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-ol/one analogs and their derivatives.
P2860
Anti-angiogenesis approach to genitourinary cancer treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anti-angiogenesis approach to genitourinary cancer treatment.
@en
Anti-angiogenesis approach to genitourinary cancer treatment.
@nl
type
label
Anti-angiogenesis approach to genitourinary cancer treatment.
@en
Anti-angiogenesis approach to genitourinary cancer treatment.
@nl
prefLabel
Anti-angiogenesis approach to genitourinary cancer treatment.
@en
Anti-angiogenesis approach to genitourinary cancer treatment.
@nl
P2860
P1476
Anti-angiogenesis approach to genitourinary cancer treatment
@en
P2093
William L Dahut
P2860
P304
P356
10.1016/J.UCT.2009.05.002
P577
2009-01-01T00:00:00Z